Parathyroid Hormone Analog Market

Parathyroid Hormone Analog Market contains market size and forecasts of Parathyroid Hormone Analog in global, including the following market information:

• Global Parathyroid Hormone Analog Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Parathyroid Hormone Analog Market Sales, 2017-2022, 2023-2028, (K Pcs)
• Global top five Parathyroid Hormone Analog companies in 2021 (%)

The global Parathyroid Hormone Analog market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Abaloparatide Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Parathyroid Hormone Analog include Pfizer, Abbott Laboratories, Merck, Natpara, GlaxoSmithKline Plc, Sanofi SA, Eli Lilly, Cell Genesys Inc and OSI Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Parathyroid Hormone Analog manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Parathyroid Hormone Analog Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Parathyroid Hormone Analog Market Segment Percentages, by Type, 2021 (%)

• Abaloparatide
• Teriparatide
• Human Parathyroid Hormone Recombinant

Global Parathyroid Hormone Analog Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Parathyroid Hormone Analog Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Other

Global Parathyroid Hormone Analog Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Parathyroid Hormone Analog Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Parathyroid Hormone Analog revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Parathyroid Hormone Analog revenues share in global market, 2021 (%)
• Key companies Parathyroid Hormone Analog sales in global market, 2017-2022 (Estimated), (K Pcs)
• Key companies Parathyroid Hormone Analog sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• Abbott Laboratories
• Merck
• Natpara
• GlaxoSmithKline Plc
• Sanofi SA
• Eli Lilly
• Cell Genesys Inc
• OSI Pharmaceuticals
• Paladin Labs Inc
• ALZA Corporation